MELD Calculator vs AGA MASH App

This update introduces the landmark MELD 3.0 formula, addressing long-standing gender disparities and improving mortality prediction. Key Features: MELD 3.0, Na-MELD, and Original MELD: View all three scores simultaneously on a single, high-density dashboard. Survival Probabilities: Real-time prediction of 30, 60, and 90-day survival based on the latest peer-reviewed hazard models. Clinical Accuracy: Implements the exact coefficients and bounds proposed in the 2021 MELD 3.0 research. Modern Aesthetic: A premium, minimalist design optimized for the iPhone, ensuring zero clutter and immediate visibility of critical metrics. Designed for Efficiency: Automated calculations and smart focus management allow for rapid data entry in fast-paced clinical environments. Scientific Reference: Based on the research: Kim WR, et al. "MELD 3.0: The Model for End-stage Liver Disease Updated for the Modern Era." Gastroenterology (2021). Disclaimer: This tool is intended for educational and professional use by healthcare providers. It is not a substitute for clinical judgment.

American Gastroenterological Association’s MASH Clinical Care Pathway app is for use in any setting where health care professionals care for patients with MASH / MASLD, including primary care, endocrine, obesity medicine and gastroenterology practices. Developed with support by independent medical education grants from Intercept Pharmaceuticals, Inc., Pfizer Inc., Allergan, and Genfit. For more information visit gastro.org.